Gene therapy of cancer

Lancet

Volumn 349, Issue SUPPL.2, 1997, Pages

  Weichselbaum, Ralph R ^a   Kufe, Donald ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOTOXIC AGENT; LIPOSOME; PROTEIN P53;

ADENOVIRUS; CANCER; DRUG RESISTANCE; EXPRESSION VECTOR; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSDUCTION; HERPES VIRUS; HUMAN; PRIORITY JOURNAL; RETROVIRUS; SHORT SURVEY; TRANSGENE; TUMOR SUPPRESSOR GENE;

EID: 0031006256     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0140-6736(97)90013-1     Document Type: Article

References (31)

1. Fine HA, Kufe DW. Cancer gene therapy. In: Holland JF, Bast RC Jr, Morton DL, Frei E, Kufe DW, Weichselbaum RR, eds. Cancer medicine. 4th ed. Baltimore: Williams & Wilkins, 1997: 1265-75.
2. Miller AD. Retroviral vectors. Curr Topics Microbiol Immunol 1992; 158: 1-24.
3. Berkner KL. Expression of heterologous sequences in adenoviral vector. Curr Topics Microbiol Immunol 1992; 158: 39-66.
4. Horowitz MS. Adenoviridae and their replication. In: Fields BN, Knipe DM, eds. Fundamental virology. 2nd ed. New York: Raven, 1991: 771-813.
5. Roizman B, Sears AE. Herpes virus and their replication. In: Fields BN, Knipe DM, eds. Virology. New York: Raven, 1991: 1795-842.
6. Wolff JA, Budker V. Cationic lipid-mediated gene transfer. In: Sobol RE, Scanlon KJ, eds. Internet book of gene therapy. Stamford, Connecticut: Appleton & Lange, 1995: 65-73.
7. Manthorpe M, Cornefert-Jensen F, Hartikka J, et al. Gene therapy by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in mice. Hum Gene Ther 1993; 4: 419-31.
8. Wagner E, Zatloukal K, Gotten M, et al. Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. Proc Natl Acad Sci USA 1992; 89: 6099-103.
9. Rettinger SD, Kennedy SC, Wu X, et al. Liver-directed gene therapy: quantitative evaluation of promoter elements by using in vivo retroviral transduction. Proc Natl Acad Sci USA 1994; 91: 1460-64.
10. Huber BE, Austin EA, Good SS, Knick VC, Tibbels S, Richards CA. In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase. Cancer Res 1993; 53: 4619-26.
11. Wen P, Crawford N, Locker J. A promoter-linked coupling region required for stimulation of alpha-fetoprotein transcription by distant enhancers. Nucleic Acids Res 1993; 21: 1911-18.
12. Chen L, Chen D, Manome Y, Dong Y, Fine HA, Kufe DW. Breast cancer selective gene expression and therapy mediated by recombinant adenoviruses containing the DF3/MUC1 promoter. J Clin Invest 1995; 96:2775-82.
13. Hallahan DE, Mauceri HJ, Seung LP, et al. Spatial and temporal control of gene therapy using ionizing radiation. Nat Med 1995; 1: 786-91.
14. Moolten FL. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res 1986; 46: 5276-81.
15. Freeman SM, Abboud CN, Whartenby KA, et al. The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 1993; 53: 5274-83.
16. Wei MX, Tamiya T, Hurford R Jr., Boviatsis EJ, Tepper RI, Chiocca EA. Enhancement of interleukin-4-mediated tumor regression in athymic mice by in situ retroviral gene transfer. Hum Gene Ther 1995; 6: 437-43.
17. Dalgleish AG. The role of IL-2 in gene therapy. Gene Ther 1994; 1: 83-87.
18. Chen L, Ashe S, Brady WA, et al. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 1992; 71: 1093-102.
19. Tsang KY, Zaremba S, Nieroda CA, Zhu MZ, Hamilton JM, Schlom J. Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinent vaccina-CEA vaccine. J Natl Cancer Inst 1995; 87: 982-90.
20. Wang B, Merva M, Dang K, Ugen KE, Williams WV, Weiner DB. Immunization by direct DNA inoculation induces rejection of tumor cell challenge. Hum Gene Ther 1995; 6: 407-18.
21. Wills KN, Maneval DC, Menzel P, et al. Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer. Hum Gene Ther 1994; 5: 1079-88.
22. Kashani-Sabet M, Scanlon KJ. Application of ribozymes to cancer gene therapy. In: Sobol RE, Scanlon KJ, eds. Internet book of gene therapy. Stamford, Connecticut: Appleton & Lange, 1995: 91-101.
23. Stein CA, Cheng YC. Antisense oligonucleotides as therapeutic agents - is the bullet really magical? Science 1993; 261: 1004-12.
24. Podda S, Ward M, Himelstein A, et al. Transfer and expression of the human multiple drug resistance gene into live mice. Proc Natl Acad Sci USA 1992; 89: 9676-80.
25. Brenner MK, Rill DR, Moen RC, et al. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 1993; 341:85-86.
26. Chen L, Pulsipher M, Chen D, et al. Selective transgene expression for detection and elimination of contaminating carcinoma cells in hematopoietic stem cell sources. J Clin Invest 1996; 98: 2539-48.
27. Nabel GJ, Nabel EG, Yang ZY, et al. Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proc Natl Acad Sci USA 1993; 90:11307-11.
28. Borysiewicz LK, Fiander A, Nimako M, et al. A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer. Lancet 1996; 347: 1523-27.
29. Roth JA, Nguyen D, Lawrence DD, et al. Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer Nat Med 1996; 2: 985-91.
30. Sobol RE, Scanlon KJ. Clinical protocols worldwide. Cancer Gene Ther 1996; 3: 265-78.
31. Roth JA, Cristiano RJ. Gene therapy for cancer - what have we done and where are we going? J Natl Cancer Inst 1997; 89: 21-39.